15-deoxy-Δ12,14-prostaglandin J2 induces upregulation of multidrug resistance-associated protein 1 via Nrf2 activation in human breast cancer cells

Annals of the New York Academy of Sciences

Volumn 1171, Issue , 2009, Pages 210-216

  Song, Na Young ^a   Kim, Do Hee ^a   Kim, Eun Hee ^a   Na, Hye Kyung ^a   Surh, Young Joon ^a  

^a Seoul National University   (South Korea)

Author keywords

15 deoxy 12,14 prostaglandin J2; Multidrug resistance associated protein 1; Nrf2

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 9,10 DIHYDRO 15 DEOXY DELTA 12,14 PROSTAGLANDIN J2; CYCLOPENTENONE; DNA; MULTIDRUG RESISTANCE PROTEIN 1; PROSTAGLANDIN DERIVATIVE; TRANSCRIPTION FACTOR NRF1; UNCLASSIFIED DRUG;

BREAST CANCER; CELL NUCLEUS; CELL STRAIN MCF 7; CONFERENCE PAPER; CONTROLLED STUDY; ELECTROPHORESIS; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; KNOCKOUT GENE; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEOMICS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 69149085422     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04914.x     Document Type: Conference Paper

References (35)

1. Deeley, R.G., C. Westlake S.P. Cole. 2006. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol. Rev. 86 : 849 899.
2. Hayashi, A. et al. 2003. Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts. Biochem. Biophys. Res. Commun. 310 : 824 829.
3. Hayes, J.D. M. McMahon. 2006. The double-edged sword of Nrf2: subversion of redox homeostasis during the evolution of cancer. Mol Cell. 21 : 732 734.
4. Alam, J. et al. 1999. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 274 : 26071 26078.
5. Hayes, J.D., J.U. Flanagan I.R. Jowsey. 2005. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45 : 51 88.
6. Joung, E.J. et al. 2007. Capsaicin induces heme oxygenase-1 expression in HepG2 cells via activation of PI3K-Nrf2 signaling: NAD(P)H:quinone oxidoreductase as a potential target. Antioxid. Redox Signal. 9 : 2087 2098.
7. Lee, T.D. et al. 2005. Cloning and characterization of the human glutathione synthetase 5'-flanking region. Biochem. J. 390 : 521 528.
8. McMahon, M. et al. 2003. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J. Biol. Chem. 278 : 21592 21600.
9. Itoh, K., K.I. Tong M. Yamamoto. 2004. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic. Biol. Med. 36 : 1208 1213.
10. Zipper, L.M. R.T. Mulcahy. 2002. The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm. J. Biol. Chem. 277 : 36544 36552.
11. Lee, J.S. Y.J. Surh. 2005. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett. 224 : 171 184.
12. Vollrath, V. et al. 2006. Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene. Biochem. J. 395 : 599 609.
13. Keppler, D. 1999. Export pumps for glutathione S-conjugates. Free Radic. Biol. Med. 27 : 985 991.
14. Gottesman, M.M., T. Fojo S.E. Bates. 2002. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2 : 48 58.
15. Priebe, W. et al. 1998. Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump. Biochem. Biophys. Res. Comm. 247 : 859 863.
16. Ishikawa, T. et al. 1996. Coordinated induction of MRP/GS-X pump and gamma-glutamylcysteine synthetase by heavy metals in human leukemia cells. J. Biol. Chem. 271 : 14981 14988.
17. Ogretmen, B. et al. 1998. Co-ordinated over-expression of the MRP and gamma-glutamylcysteine synthetase genes, but not MDR1, correlates with doxorubicin resistance in human malignant mesothelioma cell lines. Int. J. Cancer 75 : 757 761.
18. O'Brien, M., G.D. Kruh K.D. Tew. 2000. The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance. J. Pharmacol. Exp. Ther. 294 : 480 487.
19. Straus, D.S. C.K. Glass. 2001. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med. Res. Rev. 21 : 185 210.
20. 2-induced expression of glutathione S-transferases. J. Biol. Chem. 275 : 11291 11299.
21. 2 as a potential endogenous regulator of redox-sensitive transcription factors. Biochem. Pharmacol. 72 : 1516 1528.
22. Levonen, A.L. et al. 2004. Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem. J. 378 : 373 382.
23. Zhang, D.D. M. Hannink. 2003. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell Biol. 23 : 8137 8151.
24. Eggler, A.L. et al. 2005. Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proc. Natl. Acad. Sci. USA 102 : 10070 10075.
25. 2 metabolite generated during inflammatory processes. J. Biol. Chem. 277 : 10459 10466.
26. 2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells. Cancer Res. 59 : 2739 2746.
27. 2 in a model of skin carcinogenesis. Carcinogenesis 27 : 328 336.
28. 2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells. Ann. N. Y. Acad. Sci. 1090 : 375 384.
29. 2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS. Carcinogenesis 29 : 688 695.
30. 2: an electrophilic trigger of cellular responses. Chem. Res. Toxicol. 21 : 138 144.
31. Itoh, K. et al. 1999. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13 : 76 86.
32. Kang, M.I. et al. 2004. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc. Natl. Acad. Sci. USA 101 : 2046 2051.
33. Nguyen, T. et al. 2003. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J. Biol. Chem. 278 : 4536 4541.
34. Dinkova-Kostova, A.T., W.D. Holtzclaw N. Wakabayashi. 2005. Keap1, the sensor for electrophiles and oxidants that regulates the phase 2 response, is a zinc metalloprotein. Biochemistry 44 : 6889 6899.
35. Na, H.K. Y.J. Surh. 2006. Transcriptional regulation via cysteine thiol modification: a novel molecular strategy for chemoprevention and cytoprotection. Mol. Carcinog. 45 : 368 380.